✦ LIBER ✦

Doxycycline versus ceftriaxone for the treatment of patients with chronic Lyme borreliosis

✍ Scribed by Katarina Ogrinc; Mateja Logar; Stanka Lotrič-Furlan; Daša Cerar; Eva Ružić-Sabljić; Franc Strle

Publisher: Springer Vienna
Year: 2006
Tongue: English
Weight: 123 KB
Volume: 118
Category: Article
ISSN: 0043-5325
DOI: 10.1007/s00508-006-0698-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized trial of ceftriaxone versus

A randomized trial of ceftriaxone versus oral penicillin for the treatment of early european lyme borreliosis

✍ K. Weber; Vera Preac-Mursic; Bettina Wilske; R. Thurmayr; U. Neubert; C. Scherwi 📂 Article 📅 1990 🏛 Springer-Verlag 🌐 English ⚖ 970 KB

Azithromycin versus penicillin V for the

Azithromycin versus penicillin V for the treatment of early lyme borreliosis

✍ K. Weber; Bettina Wilske; Vera Preac-Mursic; R. Thurmayr 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 940 KB

Effectiveness of ceftriaxone plus doxycy

Effectiveness of ceftriaxone plus doxycycline in the treatment of patients hospitalized with community-acquired pneumonia

✍ Scott A. Flanders; Vicky Dudas; Kathleen Kerr; Charles E. McCulloch; Ralph Gonza 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Pre-treatment and post-treatment assessm

Pre-treatment and post-treatment assessment of the C6test in patients with persistent symptoms and a history of Lyme borreliosis

✍ R. V. Fleming; A. R. Marques; M. S. Klempner; C. H. Schmid; L. G. Dally; D. S. M 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 83 KB

Quetiapine versus olanzapine for the tre

Quetiapine versus olanzapine for the treatment of negative symptoms in patients with schizophrenia

✍ Pinkhas Sirota; Irit Pannet; Ady Koren; Eleonora Tchernichovsky 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract Negative symptoms are considered the most debilitating and refractory aspect of schizophrenia, being associated with poor social, occupational and global outcomes. Conventional antipsychotics have limited efficacy against these symptoms and poor tolerability profiles. Atypical antipsych

The ethics of placebo treatment for pati

The ethics of placebo treatment for patients with acute exacerbation of chronic hepatitis B

✍ Gin-Ho Lo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

I can hardly share the passionate enthusiasm of Breuhahn et al. for the ''dramatic'' improvements in understanding of molecular pathogenesis of hepatocellular carcinoma (HCC) and the claim for ''further rationally designed clinical trials based on molecular evidence''. 1 Among the causes of HCC, the